FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101868 [Registered on: 23/01/2026] Trial Registered Prospectively
Last Modified On: 22/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda
Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Efficacy of Sharkarayukta Bhunimba kalka and tab doxinate in Garbhini Chardi 
Scientific Title of Study   An Open Randomised Controlled Clinical Trial to evaluate the efficacy of Sharkarayukta Bhunimba kalka in Garbhini Chardi with special reference to Emesis Gravidarum 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR SANGEETA SAVALARAM CHAUDHARY 
Designation  PG Scholar 
Affiliation  Dr G D Pol Foundation YMT Ayurvedic Medical College and Hospital 
Address  DR G D POL FOUNDATION, YMT Ayurvedic Medical College and Hospital, 3rd floor, Gynaec Dept, Sector-4, Kharghar, Navi Mumbai,Raigarh

Raigarh
MAHARASHTRA
410210
India 
Phone  9021855959  
Fax    
Email  sangeetachaudhary275@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR PRANALI DANDEKAR 
Designation  Associate Professor, PG Guide,MD(Ayu) 
Affiliation  Dr G D Pol Foundation YMT Ayurvedic Medical College and Hospital 
Address  DR G D POL FOUNDATION, YMT Ayurvedic Medical College and Hospital, 3rd floor, Gynaec Dept, Sector-4, Kharghar, Navi Mumbai,Raigarh

Raigarh
MAHARASHTRA
410210
India 
Phone  9619020010  
Fax    
Email  pranalibhardwaj@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SANGEETA SAVALARAM CHAUDHARY 
Designation  PG Scholar 
Affiliation  Dr G D Pol Foundation YMT Ayurvedic Medical College and Hospital 
Address  DR G D POL FOUNDATION, YMT Ayurvedic Medical College and Hospital, 3rd floor, Gynaec Dept, Sector-4, Kharghar, Navi Mumbai,Raigarh

Raigarh
MAHARASHTRA
410210
India 
Phone  9021855959  
Fax    
Email  sangeetachaudhary275@gmail.com  
 
Source of Monetary or Material Support  
DR G D POL FOUNDATION,YMT Ayurvedic Medical College And Hospital, Sector-4,Kharghar,Navi Mumbai,Maharashtra 410210,India  
 
Primary Sponsor  
Name  Dr Sangeeta Savalaram Chaudhary 
Address  Dr G D POL FOUNDATION,YMT Ayurvedic Medical College and Hospital,3rd Floor,Gynaec Dept,Sector-4,Kharghar,Navi Mumbai,Maharashtra 410210,India 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sangeeta Savalaram Chaudhary  Dr G D Pol Foundation YMT Ayurvedic Medical College and Hospital  3rd Floor, Gynaec Dept, Sector-4, Kharghar, Navi Mumbai
Raigarh
MAHARASHTRA 
9021855959

sangeetachaudhary275@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Dr G D Pol Foundation YMT Ayurvedic Medical College and charitable hospital,Kharghar,Navi Mumbai   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O219||Vomiting of pregnancy, unspecified. Ayurveda Condition: GARBINYA VAMANAVYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Sharkarayukta Bhunimba Kalka, Reference: Harita Samhita Trutiya Sthana 51/6, Route: Oral, Dosage Form: Churna/ Powder, Dose: 12(g), Frequency: qid, Bhaishajya Kal: Muhurmuhu, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator Arm (Non Ayurveda)-Tab DoxinateTab Doxinate ( doxylamine succinate 10mg and pyridoxine 10mg) orally,for 7 days,empty stomach OD
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. ANC having Garbhini Chardi in first trimester of pregnancy of any gravida
2. ANC Patients having Normal ANC profile 
 
ExclusionCriteria 
Details  1. Garbhini having hyper emesis gravidarum
2. Garbhini with severe infection like TORCH,etc
3. Garbhini with systemic disorders like DM,Hypertension,etc
4. Garbhini on other medication causing nausea and vomiting 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Sharkarayukta Bhunimba Kalka in management of Garbhini Chardi with special reference to Emesis Gravidarum  1st visit- Baseline
2nd visit- 3rd day
3rd visit-7th day
4th visit-15th day 
 
Secondary Outcome  
Outcome  TimePoints 
To study & review literatue on Garbhini Chardi & emesis gravidarum  1st visit- Baseline
2nd visit- 3rd day
3rd visit-7th day
4th visit-15th day 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   03/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The Present Study is a PG Thesis Topic
By PG Scholar - DR SANGEETA SAVALARAM CHAUDHARY and Guide Nmae - DR PRANALI DANDEKAR
Title - AN OPEN RANDOMISED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFICACY OF SHARKARAYUKTA BHUNIMBA KALKA IN GARBHINI CHARDI w.s.r.t EMESIS GRAVIDARUM

According to inclusion and exclusion criteria
Group A 40 patients and Group B 40 patients will be selected
Group A ( intervention ) will be given sharkarayukta bhunimba kalka 12gm muhurmuhu QID for 7 days
Group B (control/comparative) will be given Tab Doxinate 10mg empty stomach OD for 7 days

Total Duration of study is 1 year 6 months
 
Close